A History of Prescription Drug Monitoring Programs in the United States

Political Appeal and Public Health Efficacy

Dados Bibliográficos

ID11036697
AutoresA Jay Holmgren (0000-0002-7939-6831, A. Jay Holmgren is with the Harvard Business School, Harvard University, Boston, MA. Alyssa Botelho is with the Medical Scientist Training Program, Harvard Medical School, Boston, MA, and the Department of the History of Science, Harvard University, Cambridge, MA. Allan M. Brandt is with the Department of Global Health and Social Medicine, Harvard Medical School, Boston, and the Department of the History of Science, Harvard University, Cambridge.), Alyssa Botelho (A. Jay Holmgren is with the Harvard Business School, Harvard University, Boston, MA. Alyssa Botelho is with the Medical Scientist Training Program, Harvard Medical School, Boston, MA, and the Department of the History of Science, Harvard University, Cambridge, MA. Allan M. Brandt is with the Department of Global Health and Social Medicine, Harvard Medical School, Boston, and the Department of the History of Science, Harvard University, Cambridge.), Allan M Brandt (A. Jay Holmgren is with the Harvard Business School, Harvard University, Boston, MA. Alyssa Botelho is with the Medical Scientist Training Program, Harvard Medical School, Boston, MA, and the Department of the History of Science, Harvard University, Cambridge, MA. Allan M. Brandt is with the Department of Global Health and Social Medicine, Harvard Medical School, Boston, and the Department of the History of Science, Harvard University, Cambridge.)
Ano2020
Volume110
Fascículo8
Páginas1191-1197
Data de publicação2020-08-01
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoAmerican Journal of Public Health (JOURNAL)
Identificadores do periódicoISSN: 0090-0036 • E-ISSN: 1541-0048
EditoraAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2020.305696
PMID32552023
OpenAlexW3036820098
IdiomaEN
Citações recebidas10
Referências citadas16

Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted PDMPs, and they have received strong bipartisan legislative support. This article explores the history of PDMPs, tracking their evolution from paper-based administrative databases in the early 1900s to modern-day electronic systems that intervene at the point of care. We focus on two questions: how did PDMPs become so widely adopted in the United States, and how did they gain popularity as an intervention in the contemporary opioid crisis? Through this historical approach, we evaluate what PDMPs reflect about national drug policy and broader cultural understandings of substance use disorder in the United States today. (Am J Public Health. 2020;110:1191–1197. 10.2105/AJPH.2020.305696)

Appeal · Harm reduction · Intervention (counseling) · Legislature · Political science · Popularity · Psychiatry · Public health · Law · Medicine · Nursing · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Substance Abuse Treatment and Outcomes